The Food and Drug Administration the powerful US Quango that controls the licensing of drugs, has ordered a pharmaceutical company to carry out more trials on a new weight loss drug it’s developing. Last October, the FDA rejected the drug Lorcaserin basing its decision on a possibility that the compound is a cancer risk. The […]
The United States Food and Drug Administration (FDA) refused a license for a latest weight-loss drug. The drug in question – Lorcaserin – was deemed not yet ready for approval. It seems the FDA has concerns about Lorcaserin’s effectiveness and its potential risk in increasing cancer in users. Apparently, there were higher than normal cases […]